berberine has been researched along with melatonin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dutour, R; Poirier, D | 1 |
Ding, K; Huang, L; Jiang, H; Li, X; Luo, Z; Su, T; Wang, X | 1 |
Deng, W; Fu, L; Huang, W; Lu, JJ; Qin, L; Shi, D; Tang, Z; Wang, J; Xiao, X; Xie, F; Yu, Z; Zhang, C | 1 |
Di Nicolantonio, JJ; Gálvez Ruiz, JC; Iloki Assanga, SB; Lewis Luján, LM; McCarty, MF; Plascencia-Jatomea, M; Rosas-Burgos, EC | 1 |
2 review(s) available for berberine and melatonin
Article | Year |
---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration.
Topics: AMP-Activated Protein Kinases; Berberine; Dietary Supplements; DNA, Mitochondrial; Glucosamine; Humans; Inflammasomes; Macular Degeneration; Melatonin; Mitochondria; Mitophagy; NF-E2-Related Factor 2; Organelle Biogenesis; Oxidative Stress; PPAR alpha; Retinal Pigment Epithelium; RNA; Sirtuin 1; Thioctic Acid | 2022 |
2 other study(ies) available for berberine and melatonin
Article | Year |
---|---|
Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Berberine; Cholinesterase Inhibitors; Coumaric Acids; Humans; Hydroquinones; Melatonin; Mice; Models, Molecular; Molecular Structure; Peptide Fragments; Structure-Activity Relationship | 2011 |
Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Berberine; Caspase 9; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochromes c; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Lung Neoplasms; Male; Melatonin; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Telomerase; Transcription Factor AP-2; Xenograft Model Antitumor Assays | 2016 |